Methylprednisolone can improve isolated nocturnal hypoxemia in stable COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005
Are there any patient-features to predict long-term benefit from noninvasive intermittent positive pressure ventilation (nIPPV) in patients with severe stable chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 403s Year: 2001
A meta-analysis of nocturnal noninvasive positive pressure ventilation (NIPPV) in stable patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 402s Year: 2001
Predictors of poor outcome in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) receiving noninvasive positive pressure ventilation (NPPV Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure Year: 2015
Clinical significance of episodic nocturnal hypercapnia and its treatment with non-invasive positive pressur ventilation in patients with stable advanced chronic obstructive pulmonary disease Source: International Congress 2018 – New tools for managing respiratory failure Year: 2018
How frequent is bronchodilator reversibility in patients with stable asthma bronchiale and chronic obstructive lung disease (COPD) receiving maintenance therapy? Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012
The reversibility of hypoxemia in OSA patients is related to CPAP therapy Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005
Formoterol demonstrates bronchodilator efficacy in patients with reversible or poorly reversible chronic obstructive pulmonary disease (COPD), regardless of concomitant corticosteroid use Source: Eur Respir J 2001; 18: Suppl. 33, 177s Year: 2001
How to prevent exercise-induced hypoxemia in patients with severe COPD? Source: Annual Congress 2008 - Use of noninvasive ventilation in various conditions Year: 2008
How to provide NIV in the COPD patient with chronic stable hypercapnia Source: Sleep and Breathing Conference 2017 Year: 2017
Bronchodilator responsiveness in patients with COPD Source: Eur Respir J 2008; 31: 742-750 Year: 2008
Effect of long-term bronchodilator therapy on pulmonary function tests and exercise tolerance in patients with stable chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002
Effects of long-acting bronchodilators on changes of inspiratory capacity by hyperventilation in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 430s Year: 2006
Exhaled breath markers in patients with obstructive sleep apnea (OSA): baseline assessment and the impact of treatment with nasal continuous positive airway pressure Source: Eur Respir J 2005; 26: Suppl. 49, 355s Year: 2005
Liver function following continuous positive airway pressure therapy in obstructive sleep apnea patients Source: International Congress 2017 – CPAP therapy Year: 2017
Formoterol or tiotropium bromide do not influence isolated nocturnal hypoxemia in stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 294s Year: 2005
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD Source: Eur Respir J 2010; 35: 132-137 Year: 2010
Pre-exercise inhalation of short-acting ß-agonists (SABA) safely improves exercise performance in severe COPD patients by reducing lung hyperinflation Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 19: 217-224 Year: 2002
NVA237, a once-daily anticholinergic, demonstrates sustained bronchodilation and is well tolerated in patients with reversible obstructive airways disease Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006